Report #2857403

Received Sep 8, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: 4 yrs
State: CO
Recovered: Unknown
Vaccinated: Aug 20, 2025
Onset: Aug 20, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
DTAPHEPBIP	DTAP + HEPB + IPV (PEDIARIX)	GLAXOSMITHKLINE BIOLOGICALS	UNK	A32BB	—

Symptoms (1)

Expired product administered

Symptom narrative

Pediarix expired dose administration; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 4-year-old female patient who received DTPa-HBV-IPV (Pediarix) (batch number A32BB, expiry date 10-AUG-2025) for prophylaxis. On 20-AUG-2025, the patient received Pediarix. On 20-AUG-2025, an unknown time after receiving Pediarix, the patient experienced expired vaccine used (Verbatim: Pediarix expired dose administration). The outcome of the expired vaccine used was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 20-AUG-2025 A health care provider wanted to know how to proceed after administering an expired (dose less than 30 days) of Pediarix to a patient.